4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000166
EVP, Chief Reg. & Quality Off. sold 4,600 shares at an average $441.99 ($2,033,159)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-30 | Sale : show line 1 in the form 10b5-1 | −2,350 | $439.11 | $1,031,909 | 53,523 | D |
| 2024-05-31 | Sale : show line 2 in the form 10b5-1 | −2,250 | $445.00 | $1,001,250 | 51,273 | D |
| Open-market sales · 4,600 sh · avg $441.99 · $2,033,159 | ||||||
Loading xslF345X05/wk-form4_1717445345.xml…